Status:
UNKNOWN
MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance
Lead Sponsor:
University of British Columbia
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
25+ years
Phase:
PHASE1
Brief Summary
Prostate cancer is the most common cancer in men. It is most often detected by an abnormal digital rectal exam or an elevated Prostate-Specific Antigen -determine by a blood test. When it is suspected...
Detailed Description
It is the hypothesis that cancerous lesions in the prostate will have an increased amount of blood flow, and that the lesions identified under ultrasound with the benefits of contrast-enhanced imaging...
Eligibility Criteria
Inclusion
- Adults ( aged 21 years or greater), English speaking patients
Exclusion
- Patients who are unable to provide informed consent
- Patients who have had previous reaction to any contrast agent at any point in the past
- Patients who have had previous septic infection from prostate biopsies at any point in the past
- Patients who have a right-to-left, bi-directional, or transient right-to-left cardiac shunts.
- Patients undergoing extracorporeal shock wave lithotripsy for urinary calculi.
- Patients with pre-existing cardiopulmonary compromise including, but not limited to, acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, serious ventricular arrhythmias or respiratory failure, including patients receiving mechanical ventilation
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02233725
Start Date
July 1 2014
End Date
December 1 2015
Last Update
September 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver Coastal Health (VCHRI/VCHA)
Vancouver, British Columbia, Canada, V5Z 1M9